Trends in the treatment and survival of heart failure patients:
a nationwide population-based study in the Czech Republic

J 2021

Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic

TABORSKY, Milos, Tomas SKALA, Marie LAZAROVA, Renata AIGLOVA, Jindřich ŠPINAR et. al.

Basic information

Original name

Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic

Authors

TABORSKY, Milos (203 Czech Republic), Tomas SKALA (203 Czech Republic, guarantor), Marie LAZAROVA (203 Czech Republic), Renata AIGLOVA (203 Czech Republic), Jindřich ŠPINAR (203 Czech Republic), Lenka ŠPINAROVÁ (203 Czech Republic), Jiří VÍTOVEC (203 Czech Republic), Josef KAUTZNER (203 Czech Republic), Vojtech MELENOVSKY (203 Czech Republic), Filip MALEK (203 Czech Republic), Ladislav DUŠEK (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution), Marek VICHA (203 Czech Republic) and Ales LINHART (203 Czech Republic)

Edition

ESC Heart Failure, San Francisco, Wiley Periodicals, 2021, 2055-5822

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 3.612

RIV identification code

RIV/00216224:14110/21:00123118

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1002/ehf2.13559

UT WoS

000686108700001

Keywords in English

Heart failure; Incidence; Prevalence; Treatment; European Union; Czech Republic

Abstract

V originále

Aims A retrospective nationwide observational analysis of diagnoses, procedures, and treatment reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018. Methods and results Prevalence of heart failure (HF) patients increased from 176 496 (1679.4 per 100 000 population) in 2012 to 285 745 (2689.0 per 100 000 population) patients in 2018 (mean age 74.4 +/- 12.8 years). In the last years, a stable incidence of HF patients was observed (544 per 100 000 population in 2016 vs. 551 per 100 000 population in 2018; P = 0.310). Mortality rate decreased from 20.55% in 2012 to 15.89% in 2018. The number of hospitalized patients remained similar (318.2 per 100 000 population in 2012 vs. 311.8 per 100 000 population in 2018; P = 0.479). The most used drugs were diuretics (173 295; 60.6%) and beta-blockers (178 823; 62.6%), followed by angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (angiotensin-converting enzyme inhibitors 120.581; 42.2%; angiotensin II receptor blockers 47 216; 16.5%). Even though the whole number of implanted devices in HF patients increased steadily (from 25 205 in 2012 to 45 363 in 2018), the prevalence of all devices (pacemakers and defibrillators) in the HF patients remained about the same (14.3% in 2012; 15.9% in 2018). Conclusions The study included all patients with HF in the Czech Republic. These are the first nationwide data of HF epidemiology in the Eastern bloc. The incidence of HF remains stable in the last years. Due to aging of the population, the prevalence of HF significantly increased in the last 6 years. Despite a continuous increase in the prevalence of HF and a suboptimal utilization of its pharmacological therapy, mortality decreased, and the number of hospitalized patients remained the same.

Citovat

TABORSKY, Milos, Tomas SKALA, Marie LAZAROVA, Renata AIGLOVA, Jindřich ŠPINAR, Lenka ŠPINAROVÁ, Jiří VÍTOVEC, Josef KAUTZNER, Vojtech MELENOVSKY, Filip MALEK, Ladislav DUŠEK, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Marek VICHA and Ales LINHART. Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic. ESC Heart Failure. San Francisco: Wiley Periodicals, 2021, vol. 8, No 5, p. 3800-3808. ISSN 2055-5822. Available from: https://dx.doi.org/10.1002/ehf2.13559.

@article{1807766,
   author = {Taborsky, Milos and Skala, Tomas and Lazarova, Marie and Aiglova, Renata and Špinar, Jindřich and Špinarová, Lenka and Vítovec, Jiří and Kautzner, Josef and Melenovsky, Vojtech and Malek, Filip and Dušek, Ladislav and Jarkovský, Jiří and Benešová, Klára and Vicha, Marek and Linhart, Ales},
   article_location = {San Francisco},
   article_number = {5},
   doi = {http://dx.doi.org/10.1002/ehf2.13559},
   keywords = {Heart failure; Incidence; Prevalence; Treatment; European Union; Czech Republic},
   language = {eng},
   issn = {2055-5822},
   journal = {ESC Heart Failure},
   title = {Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic},
   url = {https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13559},
   volume = {8},
   year = {2021}
}

TY  - JOUR
ID  - 1807766
AU  - Taborsky, Milos - Skala, Tomas - Lazarova, Marie - Aiglova, Renata - Špinar, Jindřich - Špinarová, Lenka - Vítovec, Jiří - Kautzner, Josef - Melenovsky, Vojtech - Malek, Filip - Dušek, Ladislav - Jarkovský, Jiří - Benešová, Klára - Vicha, Marek - Linhart, Ales
PY  - 2021
TI  - Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic
JF  - ESC Heart Failure
VL  - 8
IS  - 5
SP  - 3800-3808
EP  - 3800-3808
PB  - Wiley Periodicals
SN  - 20555822
KW  - Heart failure
KW  - Incidence
KW  - Prevalence
KW  - Treatment
KW  - European Union
KW  - Czech Republic
UR  - https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13559
N2  - Aims A retrospective nationwide observational analysis of diagnoses, procedures, and treatment reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018. Methods and results Prevalence of heart failure (HF) patients increased from 176 496 (1679.4 per 100 000 population) in 2012 to 285 745 (2689.0 per 100 000 population) patients in 2018 (mean age 74.4 +/- 12.8 years). In the last years, a stable incidence of HF patients was observed (544 per 100 000 population in 2016 vs. 551 per 100 000 population in 2018; P = 0.310). Mortality rate decreased from 20.55% in 2012 to 15.89% in 2018. The number of hospitalized patients remained similar (318.2 per 100 000 population in 2012 vs. 311.8 per 100 000 population in 2018; P = 0.479). The most used drugs were diuretics (173 295; 60.6%) and beta-blockers (178 823; 62.6%), followed by angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (angiotensin-converting enzyme inhibitors 120.581; 42.2%; angiotensin II receptor blockers 47 216; 16.5%). Even though the whole number of implanted devices in HF patients increased steadily (from 25 205 in 2012 to 45 363 in 2018), the prevalence of all devices (pacemakers and defibrillators) in the HF patients remained about the same (14.3% in 2012; 15.9% in 2018). Conclusions The study included all patients with HF in the Czech Republic. These are the first nationwide data of HF epidemiology in the Eastern bloc. The incidence of HF remains stable in the last years. Due to aging of the population, the prevalence of HF significantly increased in the last 6 years. Despite a continuous increase in the prevalence of HF and a suboptimal utilization of its pharmacological therapy, mortality decreased, and the number of hospitalized patients remained the same.
ER  -

TABORSKY, Milos, Tomas SKALA, Marie LAZAROVA, Renata AIGLOVA, Jindřich ŠPINAR, Lenka ŠPINAROVÁ, Jiří VÍTOVEC, Josef KAUTZNER, Vojtech MELENOVSKY, Filip MALEK, Ladislav DUŠEK, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Marek VICHA and Ales LINHART. Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic. \textit{ESC Heart Failure}. San Francisco: Wiley Periodicals, 2021, vol.~8, No~5, p.~3800-3808. ISSN~2055-5822. Available from: https://dx.doi.org/10.1002/ehf2.13559.

Detailed Information on Publication Record